David Westerman

基本信息

Career Trajectory

Bio

He has broad clinical and laboratory interests including flow cytometry, molecular haematology and biomarkers which are reflected in his numerous peer reviewed publications.

Research Interests

Papers共 229 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia

Martin Vu,Koen Degeling,Ella R. Thompson,Piers Blombery,David Westerman,Maarten J. IJzerman

APPLIED HEALTH ECONOMICS AND HEALTH POLICY（2024）

Cited0Views0WOSBibtex

Economic Impact of Whole Genome Sequencing and Whole Transcriptome Sequencing Versus Routine Diagnostic Molecular Testing to Stratify Patients with B-Cell Acute Lymphoblastic Leukemia

Martin Vu,Koen Degeling,Georgina L. Ryland,Oliver Hofmann,Ashley P. Ng,David Westerman,Maarten J. Ijzerman

Journal of Molecular Diagnosticsno. 8 (2024): 673-684

Cited0Views0WOSBibtex

P-349 Impact of an Aurora Kinase Inhibitor on AML Cells and Mouse Ovarian Follicles in Vitro

D. Gook, S. Witts,D. Westerman,Y. Jayasinghe,C. Andersen,K. Stern

Human Reproduction（2024）

Cited0Views0Bibtex

Refined Immunophenotypic Criteria Using CD184 and CD165 Improves Sensitivity of Identification of ETP T-ALL

Monica Singh,David Westerman,Stuart S. Winter,Kimberly P. Dunsmore,David T. Teachey,Rawan Shraim,Petri Pölönen, Charles G. Mullighan,Brent L. Wood

Bloodno. Supplement 1 (2024): 5923-5923

Cited0Views0Bibtex

T-cell Clones of Uncertain Significance in the Era of Increasingly Sensitive Flow-Cytometry Detection

Tessa Potezny,Kylie Baldwin,Vuong Nguyen,Neil Came,Phillip C. Nguyen,David A. Westerman

Pathology（2024）

Cited0Views0Bibtex

Scenario Analysis and Multi-Criteria Decision Analysis to Explore Alternative Reimbursement Pathways for Whole Genome Sequencing for Blood Cancer Patients

Martin Vu,Koen Degeling,David Westerman,Maarten J. IJzerman

JOURNAL OF CANCER POLICY (2024)

Cited0Views0WOSBibtex

Sonrotoclax and Zanubrutinib As Frontline Treatment for CLL Demonstrates High MRD Clearance Rates with Good Tolerability: Data from an Ongoing Phase 1/1b Study BGB-11417-101

Jacob D. Soumerai,Chan Y. Cheah,Mary Ann Anderson,Masa Lasica,Emma Verner,Stephen S. Opat,Shuo Ma,Robert Weinkove,Raul Cordoba,Paolo Ghia,Sophie Leitch,David Westerman,Sheel Patel,Yiqian Fang, Wei Ding,Haiyi Guo,Constantine S. Tam

Bloodno. Supplement 1 (2024): 1012-1012

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Head of Haematopathology

Papers共 229 篇Author StatisticsCo-AuthorSimilar Experts